Speed and Efficiency in Designing and Building a Monoclonal Antibodies Pilot Plant - A close-up look at Pfizer's biotherapeutics plant under development in Shanbally, Ireland. - BioPharm International

ADVERTISEMENT

Speed and Efficiency in Designing and Building a Monoclonal Antibodies Pilot Plant
A close-up look at Pfizer's biotherapeutics plant under development in Shanbally, Ireland.


BioPharm International
Volume 22, Issue 3

CONCLUSION

Currently, the Shanbally plant construction is more than 60% complete and the commissioning and qualification activity is just starting. Project team members who were formerly involved with the project design phase have transitioned to commissioning activities. Recently hired Shanbally plant colleagues will participate in equipment commissioning activities as part of their education and development program.

Other teams are developing plant manufacturing and quality systems in preparation for plant start up, with engineering batches planned for 2009. There is a detailed operation readiness plan in place and we are currently 30% complete in this area. The laboratories will come online in March 2009, and will be ready to support testing of the initial production batches.

As Shanbally's finishing touches come together and the plant nears completion, the hard work of hundreds of people, inside and outside the company, brings Pfizer another step closer to its objective.

Desmond Fitzgerald is the project leader of the Shanbally project and Ken Bradley is the site leader at the Shanbally plant, both of Pfizer Inc, Shanbally, Ireland, +353 21 500 7947,

REFERENCES

1. Wagenigen University [homepage on the Internet]. Wagenigen, the Netherlands: Innovation in Biopharmaceutical Process Development and Manufacturing; 2006 [cited 2009 Jan]. Available from: http://www.bionovations.org/.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

GPhA Issues Statement on Generic Drug Costs
November 20, 2014
Amgen Opens Single-Use Manufacturing Plant in Singapore
November 20, 2014
Manufacturing Issues Crucial to Combating Ebola
November 20, 2014
FDA Requests Comments on Generic Drug Submission Criteria
November 20, 2014
USP Joins Chinese Pharmacopoeia Commission for Annual Science Meeting
November 20, 2014
Author Guidelines
Source: BioPharm International,
Click here